Abstract
Aortic regurgitation is a common valvular heart disease. Aortic regurgitation may be caused by an acute mechanism of valve failure (endocarditis, aortic dissection), but most cases are secondary to chronic disease of the aortic valve or ascending aorta abnormalities. Patients remain asymptomatic for a long period before symptoms (dyspnea and angina) develop. Physical examination raises clinical suspicion but diagnosis is confirmed by echocardiography which determines mechanism, aetiology, and severity of the AR. Cardiac magnetic resonance and cardiac computed tomography may also be useful. No medical treatment has proved clinical benefit and surgery by aortic valve repair or replacement is the only effective treatment.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, Lehman B, Benjamin EJ. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999;83(6):897–902.
Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231–43.
Akinseye OA, Aradhana Pathak A, Ibebuogu UN. Aortic valve regurgitation: a comprehensive review. Curr Probl Cardiol. 2018;43:315–34.
Tornos P, Evangelista A, Bonow RO. Aortic regurgitation. In: Otto C, Bonow RO, editors. Valvular heart disease: a companion to Braunwald’s heart disease. 4th ed. Philadelphia: Saunders; 2013. p. 163–78.
Maurer G. Aortic regurgitation. Heart. 2006;92:994–1000.
Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30:303–71.
Lancellotti P, Tribouilloy C, Hagendorff A, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013;14:611–44.
Nienaber CA, von KY, Nicholas V, et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med. 1993;328:1–9.
Cigarroa JE, Isselbacher EM, DeSanctis RW, et al. Diagnostic imaging in the evaluation of suspected aortic dissection: old standards and new directions. N Engl J Med. 1993;328:35–43.
Habib G, Lancellotti P, Antunes MJ, et al. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015;36:3075–123.
Kallenbach K, Oelze T, Salcher R, et al. Evolving strategies for treatment of acute aortic dissection type A. Circulation. 2004;110(Suppl II):II-243–9.
Habib G, Avierinos JF, Thuny F. Aortic valve endocarditis: is there an optimal surgical timing? Curr Opin Cardiol. 2007;22:77–83.
Cabell CH, Abrutyn E, Fowler VG, et al. Use of surgery in patients with native valve endocarditis: results from the international collaboration on endocarditis merged database. Am Heart J. 2005;150:1092–8.
Aksoy O, Sexton DJ, Wang A, et al. Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis. 2007;44:364–72.
Roberts WC, KO JM, Moore TR, et al. Causes of pure aortic regurgitation in patients having isolated aortic valve replacement in a single US tertiary hospital (1993-2005). Circulation. 2006;114:422–9.
Desjardin VA, Enriquez Sarano M, Tajik AJ, et al. Intensity of murmurs correlates with severity of valvular regurgitation. Am J Med. 1996;100:149–56.
Jost CHA, Turina J, Mayer K, et al. Echocardiography in the evaluation of systolic murmurs of unknown cause. Am J Med. 2000;108:614–20.
Baumgartner H, Falk V, Bax JJ, et al. The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91.
Boodhwani M, de Kerchove L, Glineur D, et al. Repair-oriented classification of aortic insufficiency: impact on surgical techniques and clinical outcomes. J Thorac Cardiovasc Surg. 2009;137:286–94.
Ewe SH, Haeck ML, Ng AC, et al. Detection of subtle left ventricular systolic dysfunction in patients with significant aortic regurgitation and preserved left ventricular ejection fraction: speckle tracking echocardiographic analysis. Eur Heart J Cardiovasc Imaging. 2015;16:992–9.
Smedsrud MK, Pettersen E, Gjesdal O, et al. Detection of left ventricular dysfunction by global longitudinal systolic strain in patients with chronic aortic regurgitation. J Am Soc Echocardiogr. 2011;24:1253–9.
Mizariene V, Grybauskiene R, Vaskelyte J, Jonkaitiene R, Pavilioniene J, Jurkevicius R. Strain value in the assessment of left ventricular function and prediction of heart failure markers in aortic regurgitation. Echocardiography. 2011;28:983–92.
Olsen NT, Sogaard P, Larsson HBW, et al. Speckle-tracking echocardiography for predicting outcome in chronic aortic regurgitation during conservative management and after surgery. JACC Cardiovasc Imaging. 2011;4:223–30.
Alashi A, Mentias A, Abdallah A, et al. Incremental prognostic utility of left ventricular global longitudinal strain in asymptomatic patients with significant chronic aortic regurgitation and preserved left ventricular ejection fraction. J Am Coll Cardiol Img. 2018;11:673–82.
Detaint D, Messika-Zeitoun D, Maalouf J, et al. Quantitative echocardiographic determinants of clinical outcome in asymptomatic patients with aortic regurgitation: a prospective study. JACC Cardiovasc Imaging. 2008;1:1–11.
Amano M, Izumi C, Imamura S, et al. Pre- and postoperative predictors of long-term prognosis after aortic valve replacement for severe chronic aortic regurgitation. Circ J. 2016;80:2460–7.
Lee JC, Branch KR, Hamilton-Craig C, Eric V, Krieger EV. Evaluation of aortic regurgitation with cardiac magnetic resonance imaging: a systematic review. Heart. 2018;104:103–10.
Chambers JB, Garbi M, Nieman K, et al. Appropriateness criteria for the use of cardiovascular imaging in heart valve disease in adults: a European Association of Cardiovascular Imaging report of literature review and current practice. Eur Heart J Cardiovasc Imaging. 2017;18:489–98.
Harris AW, Krieger EW, Kim M, et al. Cardiac magnetic resonance imaging versus transesophagealthoracic echocardiography for prediction of outcomes in chronic aortic or mitral regurgitation. Am J Cardiol. 2017;119:1074–81.
Myerson SG, d’Arcy J, Mohiaddin R, et al. Aortic regurgitation quantification using cardiovascular magnetic resonance: association with clinical outcome. Circulation. 2012;126:1452–60.
Azevedo CF, Nigri M, Higuchi ML, et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol. 2010;56:278–87.
Podlesnikar T, Delgado V, Bax JJ. Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease. Int J Cardiovasc Imaging. 2018;34:97–112.
Erbel R, Aboyans V, Boileau C, et al. The Task Force for the diagnosis and treatment of aortic diseases of the European Society of Cardiology (ESC). 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Eur Heart J. 2014;35:2873–926.
Lancellotti P, Pellikka P, Budts W, et al. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. EHJCV Imaging. 2016;17:1191–229.
Garbi M, Chambers J, Vannan MA, Lancellotti P. Valve stress echocardiography a practical guide for referral, procedure, reporting, and clinical implementation of results from the HAVEC Group. J Am Coll Cardiol Imaging. 2015;8:724–36.
Lancellotti P, Dulgheru R, Go YY, et al. Stress echocardiography in patients with native valvular heart disease. Heart. 2018;104:807–13.
Sato Y, Izumo M, Suzuki K, et al. Prognostic value of exercise left ventricular end-systolic volume index in patients with asymptomatic aortic regurgitation: an exercise echocardiography study. J Echocardiogr. 2017;15:70–8.
Wahi S, Haluska B, Pasquet A, Case C, Rimmerman CM, Marwick TH. Exercise echocardiography predicts development of left ventricular dysfunction in medically and surgically treated patients with asymptomatic severe aortic regurgitation. Heart. 2000;84:606–14.
Lee JKT, Franzone A, Lanz J, et al. Early detection of subclinical myocardial damage in chronic aortic regurgitation and strategies for timely treatment of asymptomatic patients. Circulation. 2018;137(2):184–96.
Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521–643.
Tornos MP, Olona M, Permanyer-Miralda G, et al. Clinical outcome of severe asymptomatic chronic aortic regurgitation: a long-term prospective follow-up study. Am Heart J. 1995;130:333–9.
Evangelista A, Tornos P, Sambola A, Permanyer-Miralda G, Soler-Soler J. Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med. 2005;353:1342–9.
Elder DH, Wei L, Szwejkowski BR, et al. The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study. J Am Coll Cardiol. 2011;58:2084–91.
Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC III. Angiotensin II blockade and aortic-root dilation in Marfan’s syndrome. N Engl J Med. 2008;358:2787–95.
Bisleri G. Aortic valve repair. Curr Opin Cardiol. 2016;31:581–4.
Treasure T, Takkenberg JJ, Pepper J. Surgical management of aortic root disease in Marfan syndrome and other congenital disorders associated with aortic root aneurysms. Heart. 2014;100:1571–6.
Franzone A, Piccolo R, Siontis GC, et al. Transesophageal catheter aortic valve replacement for the treatment of pure native aortic valve regurgitation: a systematic review. JACC Cardiovasc Interv. 2016;9:2308–17.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Fernández-Golfín, C. (2020). Aortic Regurgitation. In: Zamorano, J., Lancellotti, P., Pierard, L., Pibarot, P. (eds) Heart Valve Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-23104-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-23104-0_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23103-3
Online ISBN: 978-3-030-23104-0
eBook Packages: MedicineMedicine (R0)